Thomas Jefferson University
News Articles

Radiation Therapy and Cancer Vaccines: Timing Is Everything
  (PHILADELPHIA) – Radiation therapy fights cancer in more ways than one. Not only does it force cancer cells to self-destruct, but several studies demonstrate that it also ...

Paul Summergrad, M.D., President-Elect of American Psychiatric Association to Speak at Jefferson
  (PHILADELPHIA) – Paul Summergrad, M.D., Chair of the Psychiatry Department of Tufts University, Psychiatrist-in-Chief at Tufts Medical Center, and President-Elect of the American...

Two Tools Are Tested to Better Understand the Effects of Concussion on Patients’ Brains
(PHILADELPHIA) – Researchers are seeking to understand what happens inside the living brain after a concussion. In a study published in PLOS ONE, researchers at Thomas Jefferson University used...

Breast Cancer Treatment Selection Is Improved by Genomic Tests at Jefferson Breast Care Center
(PHILADELPHIA) – Genomic tests that determine the molecular subtype of a woman’s breast cancer provide a more precise prognosis and valuable guidance about the best treatment, according to...

Melissa A. Lazar, M.D. Appointed Breast Surgeon at Jefferson Breast Care Center
(PHILADELPHIA) – Thomas Jefferson University Hospital has appointed Melissa A. Lazar, M.D. as a surgeon at the Jefferson Breast Care Center. She has also been appointed an Assistant Professor of...

Novel Agent Set for Unique Clinical Test in Inflammatory Breast Cancer
  (PHILADELPHIA) A drug now used to treat a type of lymphoma has shown surprising benefit in preclinical studies of inflammatory breast cancer, according to a researcher at Thomas Jefferson...

Unique Partnership Lights Up a Parkinson’s Disease Research Tool
NEW YORK, November 12, 2013 — The Michael J. Fox Foundation for Parkinson’s Research (MJFF), Thomas Jefferson University (Jefferson) and Taconic have collaborated to create, validate and...

Cyclin D1 Governs microRNA Processing in Breast Cancer
(PHILADELPHIA) – Cyclin D1, a protein that helps push a replicating cell through the cell cycle  also mediates the processing and generation of mature microRNA (miRNA), according to new...

Making Sense of Sensation in Autism
(PHILADELPHIA) – In one of the first randomized control trials studying an intervention for sensory problems in children with autism, researchers found that occupational therapy using the...

Hollywood Films Increase Medical Students’ Empathy Toward Patients; Greater Empathy Linked to Better Patient Health
  (PHILADELPHIA) -- Medical students can be taught to be more empathetic toward patients by viewing and discussing scenes from movies that illuminate the patient’s perspective, according...

No Canine Rabies, No Canine Babies: Smaller Exposure Risks to Both Children and Adults
(Philadelphia) – Thomas Jefferson University announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Milosz Faber,...

Jefferson Comprehensive Concussion Center Opens at the Philadelphia Navy Yard
  (PHILADELPHIA)—Thomas Jefferson University Hospital, Rothman Institute and Wills Eye Hospital have collaborated to establish the Jefferson Comprehensive Concussion Center (J.C.C.C.) at...

Susan Shamimi-Noori, M.D. Appointed Assistant Professor of Radiology at Thomas Jefferson University
(PHILADELPHIA) – Susan Shamimi-Noori, M.D., an interventional radiologist, has been appointed Assistant Professor in the Department of Radiology at Thomas Jefferson University and a practicing...

Unhappy With Your Hospital? You Might Still Be Getting Great Care
  (PHILADELPHIA) - Thomas Jefferson University is releasing a study that re-examines the role of patient satisfaction in measuring hospital quality. Patient satisfaction scores are both...

Racial Difference in Blood Clotting Warrants a Closer Look at Heart Attack Medications
(PHILADELPHIA) Thomas Jefferson University researchers have discovered that the formation of blood clots follows a different molecular route in African Americans versus European Americans, providing a...

Jefferson Recognized for Expertise in Hypertension Care
(PHILADELPHIA) – The Department of Medicine at Thomas Jefferson University has been named a Comprehensive Hypertension Center by the American Society of Hypertension (ASH). Jefferson is one...

New Program Makes Prostate Cancer Treatment Decisions Easier
(PHILADELPHIA) When the pros and cons of prostate cancer treatment are spelled out using an online interactive program developed by Thomas Jefferson University researchers, more patients choose active...

3D Images Generated from PET/CT Scans Help Surgeons Envision Tumors
(PHILADELPHIA) Researchers at Jefferson Medical College in Philadelphia have developed a hologram-like display of a patient’s organs that surgeons can use to plan surgery. This approach uses...

Does Good Cholesterol Increase Breast Cancer Risk?
(PHILADELPHIA) High levels of high density lipoprotein (HDL), also known as the "good cholesterol," are thought to protect against heart disease. However, what’s good for one disease...

International Leaders in Diabetes Prevention, Treatment and Research Present at Jefferson Symposium: New Advances and Innovations
(PHILADELPHIA) – Renowned national and international leaders in diabetes prevention, treatment and research will descend on Philadelphia for the Second Annual Diabetes Symposium: New Advances...

Health Insurance Exchanges: What We Can Learn from California
(PHILADELPHIA) - Thomas Jefferson University and URAC are releasing a study that examines the role of new types of health insurance created by the Affordable Care Act (A.C.A). Starting today, under...

Jefferson Researchers Receive Department of Defense Grant to Ease Recovery for Military Personnel with Orthopaedic Injuries Sustained in Combat or Combat-related Duties
(PHILADELPHIA) – Researchers with Jefferson Orthopedics are using their experience and expertise in post-traumatic joint stiffness to develop treatments that could aid in optimal recovery and...

JSN Celebrates Faculty Publications
  On Thursday, September 26, Jefferson School of Nursing faculty ran up the Philadelphia Museum of Art steps to celebrate 100 percent of faculty submitting a manuscript for publication this...

Acid Accumulation in Breast Cancer Disables Powerful Protective Hormone
  (PHILADELPHIA) Runners often say their legs have gone sour because of the build-up of lactic acid in their muscles. Some breast tumors also produce lactic acid — and that makes them,...

Radiotherapy for Prostate Cancer has Evolved but Questions of Long-term Benefit of Newer Technologies Remain
(PHILADELPHIA)—In a review of the state of prostate cancer radiotherapy, researchers conclude that the menu of options available for men is expanding. However, given the lack of evidence proving...

A Link between Hormones and DNA Repair Provide New Clues to Treat Advanced Prostate Cancer
(PHILADELPHIA) For advanced prostate cancers, new strategies for therapeutic intervention are urgently needed, and require a better understanding of how tumor cells go from slow growth to aggressive...

Promising Prostate Cancer Treatment Should Be Considered Experimental
PHILADELPHIA— Despite the growing desire by radiation oncologist to use high-dose brachytherapy alone to treat prostate cancer, the treatment should be considered experimental at this point, say...

A Small Molecule Inhibitor of Jak2-Stat5 Signaling Pathway Stops Growth of Primary as well as Aggressive, Advanced Prostate Cancer
(PHILADELPHIA) An experimental drug targeting Jak2-Stat5 signaling blocks growth of both primary prostate cancer and prostate cancer that has become castrate-resistant, a state in which the cancer is...

Researchers Hone New Approach to Rabies Vaccine
(PHILADELPHIA) Researchers at the Jefferson Vaccine Center, report significant progress in the “holy grail” of rabies research — development of a single-dose vaccine. Currently, a...

Researchers Find New Clues to Treat Rare and Aggressive Inflammatory Breast Cancer
  A study led by investigators from Thomas Jefferson University’s Kimmel Cancer Center has discovered molecular clues that may help physicians therapeutically target inflammatory breast...

Jefferson Names Ralph J. Roberts Professorship in Cardiology
  Michael P. Savage, MD, director of the Cardiac Catheterization Laboratory and Interventional Cardiology at Thomas Jefferson University and Hospitals has been named the Ralph J. Roberts...

Protein in Blood Exerts Natural Anti-Cancer Protection
Researchers from Thomas Jefferson University’s Kimmel Cancer Center have discovered that decorin, a naturally occurring protein that circulates in the blood, acts as a potent inhibitor of tumor...

Researchers Discover Molecule That Drives Aggressive Breast Cancer
Recent studies by researchers at Thomas Jefferson University’s Kimmel Cancer Center have shown a gene known to coordinate initial development of the eye (EYA1) is a powerful breast tumor...

Need to Analyze Your Next-Generation Sequencing Data? Thomas Jefferson University’s New Web-Based Resource Makes the Task Easy
In the early 1990s, an international effort was launched by the U.S. Department of Energy and the National Institutes of Health to sequence the human genome. The project took 13 years, involved many...

Weekend Workshops in Biotechnology Start June 29
Faculty from the Department of Bioscience Technologies at Thomas Jefferson University’s Jefferson School of Health Professions are offering Weekend Workshops in Biotechnology starting June 29...

Tool to Ensure Accuracy of Radiation Treatment Plan Will Improve Quality and Save Time for Cancer Patients
It is critical that a cancer treatment plan that uses radiation be checked, and checked again, before patients are exposed to the therapy. Radiation mistakes can reduce survival, increased toxicity,...

Thomas Jefferson University Holds Commencement for Class of 2013
  PHILADELPHIA— Thomas Jefferson University will hold its 189th Annual Commencement to graduate students from Jefferson Medical College, Jefferson Graduate School of Biomedical Sciences...

Berkowitz Family Foundation Funds Lecture Highlighting Humanism in Medicine
Thomas Jefferson University has received a generous gift from Mr. Edwin Berkowitz and The Berkowitz Family Foundation of Merion, PA to fund an annual program on humanism in medicine that will attract...

Takami Sato, M.D., Named Endowed Professor of Medical Oncology in Honor of Distinguished Japanese Physicians
Internationally-recognized cancer clinician and researcher Takami Sato, M.D., Ph.D., who serves as the Director of the Metastatic Uveal Melanoma Program in the Department of Medical Oncology at Thomas...

Improving Prostate Cancer Outcomes in Ghana Could Take More Screenings, Tailored Treatments—and Breaking Down the Stigma
 Infectious diseases in Ghana tend to capture the most attention, but a quiet crisis may soon take over as the country’s most threatening epidemic: cancer. A new study published in January...

Phone and Mailed Interventions Significantly Increase Colorectal Cancer Screening Rates
A mailing or phone call to help patients get screened for colorectal cancer significantly increases their chances of actually getting tested, according to a study published in the January issue of...

Medication Errors in the Elderly Are Costing at Least $4.2 Billion Annually: Jefferson’s Proof-of-Concept Study Points to a Solution
Researchers at the Jefferson School of Population Health, working with colleagues at the Parma Local Health Authority in Italy, significantly reduced the prescribing of dangerous medications for older...

Bench to Bedside: How to Fast Track Targeted Cancer Drugs with Radiation into the Clinic
Researchers from the translational research program of the National Cancer Institute and the Radiation Therapy Oncology Therapy Group have developed new guidelines to help fast track the clinical...

Researchers at Jefferson’s Kimmel Cancer Center Discover New Pathways that Drive Metastatic Prostate Cancer
 Elevated levels of Cyclin D1b could function as a novel biomarker of lethal metastatic disease in prostate cancer patients, according to a pre-clinical study published ahead of print on December...

Game Changing Diagnostic and Prognostic Prostate Cancer Genetic Tests Revealed by Jefferson’s Kimmel Cancer Center
Researchers at the Kimmel Cancer Center at Jefferson (KCC) have developed potentially game-changing diagnostic and prognostic genetic tests shown to better predict prostate cancer survival outcomes...

Promising Drug Slows Down Advance of Parkinson’s Disease and Improves Symptoms
 Treating Parkinson’s disease patients with the experimental drug GM1 ganglioside improved symptoms and slowed their progression during a two and a half-year trial, Thomas Jefferson...

Thomas Jefferson University Honoring Cancer Pioneer Axel Ullrich with Lennox K. Black International Prize
Thomas Jefferson University will honor the renowned biotech researcher whose discoveries led to a slew of innovative drugs that revolutionized treatment including Herceptin—one of the first...

New Tumor Tracking Technique May Improve Outcomes for Lung Cancer Patients
Medical physicists at Thomas Jefferson University and Jefferson’s Kimmel Cancer Center are one step closer to bringing a new tumor-tracking technique into the clinic that delivers higher levels...

NCI Awards ‘Provocative Questions’ Grant to Thomas Jefferson University Researcher Scott Waldman
Scott Waldman, M.D., Ph.D., chairman of the Department of Pharmacology and Experimental Therapeutics at Thomas Jefferson University, has been awarded one of the prestigious “Provocative...

Thomas Jefferson University Awarded NIH Grant to Study Fibrotic Skin Disease Caused by MRI Contrast Agents
Researchers at the Jefferson Institute of Molecular Medicine were awarded almost $384,000 by the National Institutes of Health to investigate the mechanisms involved in the development of a serious...

Doubling up on Advanced Prostate Cancer with PARP-1 Inhibitors
A newly-discovered function of PARP-1 could be the key to more effective therapeutics to treat advanced prostate cancer patients, a recent, preclinical study published in Cancer Discovery by...

Stat5 Predicts Outcomes for Prostate Cancer Patients after Radical Prostatectomy
Men who had high levels of the activated Stat5 protein in their prostate cancer after a radical prostatectomy were more likely to have a recurrence or die from the disease compared to men who had...

Loss of Protective Heart Failure Protein Linked to Critical Limb Ischemia
Restoring diminished levels of a protein shown to prevent and reverse heart failure damage could also have therapeutic applications for patients with critical limb ischemia (CLI), suggests a new...

Recovering ‘Bodyguard’ Cells in Pancreas May Restore Insulin Production in Diabetics
The key to restoring production of insulin in type I diabetic patients, previously known as juvenile diabetes, may be in recovering the population of protective cells known T regulatory cells in the...

1st Annual Diabetes Symposium: New Advances and Innovations Draws Industry Leaders to Thomas Jefferson University Hospital
1st Annual Diabetes Symposium: New Advances and Innovations Draws Industry Leaders to Thomas Jefferson University Hospital   (PHILADELPHIA) – Key national and international players on the...

Large Study of Italian Diabetic Patients Confirms Physician's Empathy Directly Associated with Positive Clinical Outcomes
Patients of doctors who are more empathic have better outcomes and fewer complications, concludes a large, empirical study by a team of Thomas Jefferson University and Italian researchers who...

Jefferson School of Pharmacy Faculty Member Gerald Meyer Elected ASHP President
Gerald Meyer, MBA, PharmD, FASHP, Director of Experiential Education at the Jefferson School of Pharmacy, Thomas Jefferson University, was elected president-elect of the American Society of...

Histone Modifying Proteins, Not Histones, Remain Associated with DNA through Replication, Say Epigenetic Researchers
PHILADELPHIA—It’s widely accepted that molecular mechanisms mediating epigenetics include DNA methylation and histone modifications, but a team from Thomas Jefferson University has...

Thomas Jefferson University Renames its Graduate School
PHILADELPHIA—The Jefferson College of Graduate Studies has been renamed the Jefferson Graduate School of Biomedical Sciences (JGSBS) to better reflect the school’s breadth of degrees and...

Breast Cancer Patients Who Lack RB Gene Respond Better to Neoadjuvant Chemotherapy
Breast cancer patients whose tumors lacked the retinoblastoma tumor suppressor gene (RB) had an improved pathological response to neoadjuvant chemotherapy, researchers at Thomas Jefferson University...

Jefferson School of Pharmacy’s Doctor of Pharmacy Program Receives Accreditation
The Doctor of Pharmacy program offered by Jefferson School of Pharmacy of Thomas Jefferson University has been accredited by the Accreditation Council for Pharmacy Education. “Congratulations...

ATP: From Bystander to Actor in Kinase Regulation
A new function of ATP—beyond its passive roles as an energy source and a phosphate donor for phosphorylation reactions—was unraveled by Jefferson researchers.   Their studies...

HIV Drug May Slow Down Metastatic Breast Cancer, Researchers at Jefferson’s Kimmel Cancer Center Report
The HIV drugs known as CCR5 antagonists may also help prevent aggressive breast cancers from metastasizing, researchers from the Kimmel Cancer Center at Jefferson suggest in a preclinical study...

Japan Center Established
In January 2012 the Japan Center for Health Professions Education and Research at Jefferson was established between Thomas Jefferson University, and the Japanese Association for the Development of...

Jefferson’s Kimmel Cancer Center to Host Tribute Dinner Honoring Steve Sabol, President of NFL Films
PHILADELPHIA—Jefferson’s Kimmel Cancer Center will host a tribute dinner to honor legendary filmmaker Steve Sabol, President of NFL Films, with the Spirit of Courage Award at the Union...

A Closer Look at PARP-1 Reveals Potential New Drug Targets
A new study published in Science May 11 is shedding light on the molecular details of PARP-1, a DNA damage-detecting enzyme that when inhibited has been shown to be effective in fighting cancer and...

Jefferson Receives $2.6 Million NIH Grant to Study Imaging Method to Stage Prostate Cancer Without Biopsy
Jefferson’s Kimmel Cancer Center and the Department of Radiology at Thomas Jefferson University received a five-year, $2.6 million grant from the National Institutes of Health (NIH) to...

Nanobiotix and Thomas Jefferson University Start Research Collaboration
Paris, France and Philadelphia, USA – May 2, 2012 - Nanobiotix, a company developing novel cancer nanotherapeutics and Thomas Jefferson University, one of Philadelphia's premier medical and...

Poorer Quality of Life for Certain Subpopulations After Prostate Cancer Treatment: What Are We Missing?
PHILADELPHIA— To improve the quality of life in gay men and minorities treated for prostate cancer, a greater awareness of ethnic and sexual preference-related factors is needed to help men...

Jefferson’s Scott Waldman, M.D., Ph.D., Awarded CURE Grant to Move Colon Cancer Test Closer to Commercialization
Scott Waldman, M.D., Ph.D., Chair of the Department of Pharmacology and Experimental Therapeutics at Thomas Jefferson University, has been awarded a Commonwealth Universal Research Enhancement (CURE)...

Richard C. Gozon Named Interim President of Thomas Jefferson University
Richard C. Gozon has been appointed Interim President of Thomas Jefferson University (TJU), beginning July 1, 2012 and ending June 30, 2013, announced David R. Binswanger, TJU Board Chairman. A...

Rawls Palmer Progress in Medicine Award Presented to Dr. Scott A. Waldman
Scott A. Waldman, M.D., Ph.D., will receive the American Society for Clinical Pharmacology and Therapeutics (ASCPT) Rawls–Palmer Progress in Medicine Award at the 2012 Annual Meeting on March...

Jefferson Researcher Finds Empathy Difficult for Medical Students to Maintain; Creates Model to Improve and Sustain Students' Empathy
Philadelphia, PA — One year ago, a landmark study led by Mohammadreza Hojat, Ph.D., research professor, Department of Psychiatry and Human Behavior at Thomas Jefferson University, quantified a...

Jefferson Appoints Assistant Dean for Clinical Research
Jefferson Appoints Assistant Dean for Clinical Research ...

Stronger Intestinal Barrier May Prevent Cancer in the Rest of the Body, New Study Suggests
Philadelphia, PA — A leaky gut may be the root of some cancers forming in the rest of the body, a new study published online Feb. 21 in PLoS ONE by Thomas Jefferson University researchers...

Thomas Jefferson University's Takemi Tanaka, Ph.D, Awarded 'Refunds for Research' Grant
Philadelphia, PA — Takemi Tanaka, Ph.D., of Thomas Jefferson University’s School of Pharmacy and the Kimmel Cancer Center, received a $50,000 grant toward her breast cancer research, as...

Thomas Jefferson University Opens Health Professions Academic Building at 901 Walnut Street
Philadelphia, PA — Thomas Jefferson University will welcome trustees, donors, deans, department chairs, and its neighbors to a special ribbon-cutting ceremony on Wednesday, February 15, at...

Drugs Targeting Chromosomal Instability May Fight a Particular Breast Cancer Subtype
Philadelphia, PA — Another layer in breast cancer genetics has been peeled back. A team of researchers at Jefferson’s Kimmel Cancer Center (KCC) led by Richard G. Pestell, M.D., PhD.,...

Jefferson Researchers Mirror Human Response to Bacterial Infection and Resolution in Mice
Philadelphia, PA —Imitating human diseases using an animal model is a difficult task, but Thomas Jefferson University researchers have managed to come very close. Reporting in the Proceedings...

Thomas Jefferson University Receives Science Center's QED Award for Pancreatic Cancer Research
Philadelphia, PA — Hwyda Arafat, M.D., Ph.D., Associate Professor of Surgery at Thomas Jefferson University and co-director of the Jefferson Pancreatic, Biliary and Related Cancers Center,...

Dr. Bo Lu to Lead the Radiation Therapy Oncology Group's Lung Cancer Translational Research Program
Philadelphia, PA —The Radiation Therapy Oncology Group (RTOG) announced that Bo Lu, M.D., Ph.D., of Thomas Jefferson University and the Kimmel Cancer Center at Jefferson, has been...

Jefferson's Department of Psychiatry Receives Three-Year Suicide Prevention Grants
Philadelphia, PA — Through a grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) that was given to the Commonwealth of Pennsylvania, Thomas Jefferson University ...

Kimmel Cancer Center at Jefferson Pinpoints a New "Achilles' Heel" in Breast Cancer: Tumor Cell Mitochondria
Philadelphia, PA — Researchers at the Kimmel Cancer Center at Jefferson have identified cancer cell mitochondria as the unsuspecting powerhouse and “Achilles’ heel” of tumor...

Dean of Jefferson School of Population Health Honored by America-Israel Chamber of Commerce
Philadelphia, PA — Dr. David Nash, dean of Jefferson School of Population Health, Thomas Jefferson University, was recently honored by the America-Israel Chamber of Commerce (AICC) as one of...

Nuclear Receptors Battle it Out During Metamorphosis in New Fruit Fly Model
Nuclear Receptors Battle it Out During Metamorphosis in New Fruit Fly Model...

Jefferson School of Nursing Receives $1 Million Grant for Online Graduate Programs in Rural Underserved Communities
Jefferson School of Nursing Receives $1 Million Grant for Online Graduate Programs in Rural Underserved Communities...

Robert L. Barchi, M.D., Ph.D., to Step Down as President of Thomas Jefferson University
Robert L. Barchi, M.D., Ph.D., to Step Down as President of Thomas Jefferson University ...


Click to leave feedback
feedback